Carla S Capobianco Selected Research

Neoplasm Metastasis (Metastasis)

1/2020	Preclinical efficacy of CIGB-300, an anti-CK2 peptide, on breast cancer metastasic colonization.
1/2017	CIGB-300, an anti-CK2 peptide, inhibits angiogenesis, tumor cell invasion and metastasis in lung cancer models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carla S Capobianco Research Topics

Disease

4	Neoplasms (Cancer) 01/2022 - 01/2017
2	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2017
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2017
1	Necrosis 01/2022
1	Osteosarcoma (Osteogenic Sarcoma) 01/2022
1	Disease Progression 01/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2017
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Prostatic Neoplasms (Prostate Cancer) 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2017
1	Lewis Lung Carcinoma 01/2017

Drug/Important Bio-Agent (IBA)

3	Peptides (Polypeptides)IBA 01/2020 - 01/2017
2	CIGB-300IBA 01/2020 - 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	Propranolol (Inderal)FDA LinkGeneric 01/2022
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2020
1	Chromogranin AIBA 01/2017
1	matrigelIBA 01/2017
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 01/2017
1	NeuropeptidesIBA 01/2017
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2017
1	SynaptophysinIBA 01/2017
1	Conditioned Culture MediaIBA 01/2017
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 01/2017
1	Matrix Metalloproteinases (MMPs)IBA 01/2017
1	Casein Kinase II (Casein Kinase 2)IBA 01/2017

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2020
1	Drug Therapy (Chemotherapy) 01/2022
1	Intravenous Administration 01/2017